v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 14,431,000 $ 13,056,000
Tax credit receivable 1,696,000 3,351,000
Prepaid expenses and other current assets 630,000 1,060,000
Total Current Assets 16,757,000 17,467,000
Non-Current Assets    
Property and equipment, net 194,000 222,000
Restricted cash 45,000 46,000
Right of use asset 1,946,000 803,000
In-process research and development 19,225,000 19,619,000
Deposits and other assets 81,000 82,000
Total Assets 38,248,000 38,239,000
Current Liabilities:    
Accounts payable 608,000 1,014,000
Accrued expenses 6,220,000 6,276,000
Contingent consideration, current portion 1,193,000  
Accrued employee benefits 267,000 443,000
Deferred research and development tax credit-current portion 1,431,000 1,675,000
Loans payable-current 35,000 57,000
Operating lease liability-current portion 510,000 549,000
Total Current Liabilities 10,264,000 10,014,000
Non-current Liabilities    
Non-current contingent consideration 8,838,000 10,004,000
Loan Payable - non-current 1,626,000 1,671,000
Non-current deferred research and development tax credit 599,000 815,000
Non-current operating lease liability 1,522,000 352,000
Total Liabilities 22,849,000 22,856,000
Commitments and Contingencies (Note 14)
Stockholders' Equity:    
Common stock, $0.001 par value; 350,, shares authorized, 45,921,478 issued and 45,892,668 outstanding at March 31, 2026 and 35,717,159 issued and 35,688,350 outstanding at December 31, 2025 45,000 34,000
Additional paid-in capital 376,019,000 373,592,000
Treasury stock at cost, 28,809 shares at March 31, 2026 and at December 31, 2025 (288,000) (288,000)
Accumulated other comprehensive loss 377,000 755,000
Accumulated deficit (360,754,000) (358,710,000)
Total Stockholders' Equity 15,399,000 15,383,000
Total Liabilities and Stockholders' Equity $ 38,248,000 $ 38,239,000